Select Publications
Journal articles
, 2001, 'Is there quality in clinical benefit?', Annals of Oncology, 12, pp. 1191 - 1193, http://dx.doi.org/10.1023/A:1012474308888
, 2001, 'Management of small cell lung cancer', Expert Review of Anticancer Therapy, 1, pp. 197 - 210, http://dx.doi.org/10.1586/14737140.1.2.197
, 2000, 'Varicella-zoster infection after allogeneic bone marrow transplantation: Incidence, risk factors and prevention with low-dose aciclovir and ganciclovir', Bone Marrow Transplantation, 25, pp. 657 - 664, http://dx.doi.org/10.1038/sj.bmt.1702190
, 1999, 'An Unusual Alkaline Phosphatase Isoenzyme Associated with Gastric Carcinoma', Annals of Clinical Biochemistry International Journal of Laboratory Medicine, 36, pp. 743 - 748, http://dx.doi.org/10.1177/000456329903600607
Conference Papers
, 2026, 'Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial', in British Journal of Cancer, pp. 1152 - 1163, http://dx.doi.org/10.1038/s41416-026-03535-6
, 2025, 'AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG)', in Clinical Colorectal Cancer, pp. 120 - 128, http://dx.doi.org/10.1016/j.clcc.2024.11.003
, 2025, 'Adequate Assessment Yields Appropriate Care: The Development of an Optimal Care Pathway for Older Adults With Cancer as Part of the Australian Cancer Plan', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY
, 2025, 'Real-world outcomes of immunosuppressed patients with Merkel cell carcinoma treated with immune checkpoint inhibitors.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), pp. 9587 - 9587, http://dx.doi.org/10.1200/jco.2025.43.16_suppl.9587
, 2023, 'ASCEND: A randomised, double-blinded, phase II study of gemcitabine and nab-paclitaxel with CEND-1/LSTA1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023
, 2023, 'Circulating tumor DNA (ctDNA) as a marker of residual disease and recurrence in resected stage I-IV epithelial ovarian cancer (EOC)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023
, 2021, 'Modelling the societal outcomes of immunotherapy in cancer care in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 66 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Examining Real-World Prescribing Practices for Novel Antiandrogens in Metastatic Castration Resistant Prostate Cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 52 - 52
, 2021, 'GERIATRIC ONCOLOGY IN THE INSTAGRAM ERA: PHOTOVOICE TO ENABLE PATIENT-CENTERED CARE AND SHARED DECISION MAKING', in INNOVATION IN AGING, OXFORD UNIV PRESS, pp. 26 - 26
, 2020, 'ELderly Functional Index (ELFI): Validation of a self-reported measure of functional status in cancer patients.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020
, 2020, 'Identifying biomarkers to guide immunotherapy treatment of cancer of unknown primary.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020
, 2019, 'Avelumab treatment of metastatic merkel cell carcinoma (mMCC): Updated findings from Australian patients enrolled in an expanded access program(EAP)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 184 - 184, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400328&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Feasibility of the electronic rapid fitness assessment (eRFA) in an Australian regional cancer centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 194 - 194, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400320&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Modelling the health outcomes of immuno-oncology therapies in cancer care in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 151 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 196 - 196, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200343&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Avelumab treatment of Australian patients with metastatic Merkel cell carcinoma (mMCC): Experience from an expanded access program (EAP)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 173 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200294&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Safe Delivery of Immunotherapy: A Private Cancer Physician's Perspective', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 88 - 89, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'FIRST-LINE CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER: A NATIONAL APPROACH TO GUIDELINE RECOMMENDATIONS TO ENCOURAGE BEST PRACTICE', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 229 - 229, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), pp. 428 - 428, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.428
, 2014, 'EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), pp. 438 - 438, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.438
, 2014, 'P0201 Circulating biomarkers and outcomes in a phase 2 trial of first-line everolimus alternating with sunitinib for advanced renal cell carcinoma (ANZUP 0901—the EVERSUN Trial)', in European Journal of Cancer, Elsevier, pp. e65, http://dx.doi.org/10.1016/j.ejca.2014.03.245
, 2013, 'INTRODUCING THE NURSE PRACTITIONER ROLE TO IMPROVE REGIONAL ONCOLOGY PATIENT OUTCOMES', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 136 - 136, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800241&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'OVARIAN CANCER IN THE ELDERLY - THE ROLE OF SURGERY AND SYSTEMIC TREATMENT', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'PRACTICE PEARLS: WHAT IS DIFFERENT WHEN DEALING WITH THE OLDER PATIENT? A MEDICAL ONCOLOGIST'S PERSPECTIVE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 62 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'SURVIVAL OF AUSTRALIAN WOMEN WITH EPITHELIAL OVARIAN CANCER - A POPULATION-BASED STUDY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 81 - 81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A GCIG and EORTC-GCG study.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), pp. lba5000 - lba5000, http://dx.doi.org/10.1200/jco.2012.30.18_suppl.lba5000
, 2008, 'Renal function in the elderly', in Cancer Forum, pp. 11 - 16
, 2007, '1300 POSTER Chemotherapy in elderly patients with renal Insufficiency. Recommendations of the International Society of Geriatric Oncology (SIOG)', in European Journal of Cancer Supplements, Elsevier, pp. 174, http://dx.doi.org/10.1016/s1359-6349(07)70726-7
, 2007, '1303 POSTER Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology (SIOG) clinical practice recommendations.', in European Journal of Cancer Supplements, Elsevier, pp. 175, http://dx.doi.org/10.1016/s1359-6349(07)70729-2
, 2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, LA, New Orleans, pp. 457S - 457S, presented at 40th Annual Meeting of the American-Society-of-Clinical-Oncology, LA, New Orleans, 05 June 2004 - 08 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512401812&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2002, 'Gastro-oesophageal complications in patients receiving cancer therapy: The role of proton pump inhibitors', in European Journal of Gastroenterology and Hepatology, pp. S17 - S21
Conference Abstracts
, 2026, 'Phase Ia study of VRN101099, a brain-penetrant, highly selective covalent HER2 inhibitor, in HER2-positive or HER2-mutant advanced solid tumors.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 44, pp. 1048 - 1048, http://dx.doi.org/10.1200/jco.2026.44.16_suppl.1048
, 2026, 'Abstract LB365: Mechanistic and early clinical characterization of VRN101099, a selective HER2 inhibitor with receptor degradation activity', in Cancer Research, American Association for Cancer Research (AACR), Vol. 86, pp. lb365 - lb365, http://dx.doi.org/10.1158/1538-7445.am2026-lb365
, 2026, 'The Utility of Molecular Tumor Profiling for Patients With Advanced or Rare Cancer in a Regional Australian Setting', in Asia Pacific Journal of Clinical Oncology, http://dx.doi.org/10.1111/ajco.70059
, 2026, 'PARAGON-II COHORT C: A PHASE II BASKET STUDY OF LETROZOLE PLUS RIBOCICLIB IN HORMONE RECEPTOR POSITIVE PLATINUM-RESISTANT HIGH-GRADE EPITHELIAL OVARIAN CANCER', in International Journal of Gynecological Cancer, Elsevier, Vol. 36, pp. 105125, http://dx.doi.org/10.1016/j.ijgc.2026.105125
, 2026, 'Real-world patterns of molecular testing in Australian patients with metastatic CRPC (mCRPC)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 22, pp. S90 - S90
, 2025, '2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis', in Annals of Oncology, Elsevier, Vol. 36, pp. s1233 - s1234, http://dx.doi.org/10.1016/j.annonc.2025.08.2836
, 2024, 'Clinical impact of molecular profiling in the national prospective cohort Solving Unknown Primary Cancer (SUPER) study', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 42, presented at Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024 - 29 May 2024
, 2024, '366P Clinicopathological predictors of favourable response to docetaxel in patients with metastatic castration-resistant prostate cancer', in Annals of Oncology, Elsevier, Vol. 35, pp. s1541, http://dx.doi.org/10.1016/j.annonc.2024.10.385
, 2024, 'AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab (pan) plus 5 fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer—A trial by the Australasian Gastro-Intestinal Trials Group (AGITG).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 42, pp. 3535 - 3535, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3535
, 2024, 'Cancer of Unknown Primary-Shining light into the unknown', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 108 - 109
, 2024, 'This is Me: Revision of a co-designed resource to communicate what matters most to older adults with cancer when treatment decisions are being considered', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 214 - 215
, 2024, 'Working towards equitable age-friendly care among older adults in regional cancer care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 109 - 109
, 2022, 'Regional Victorian trials alliance: Linkages, Innovation, Special populations, Equity (ReViTALISE) project: Addressing disparity in regional populations', in Asia Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 87 - 87, presented at COSA's 49th Annual Scientific Meeting, 02 November 2022 - 04 November 2022, https://onlinelibrary.wiley.com/doi/10.1111/ajco.13868
, 2022, 'Solving unknown primary cancer - Earlier diagnosis (SUPER-ED): A stepped wedge cluster randomised controlled trial implementing a Model of Care to support earlier diagnosis', in Asia Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 143 - 144, presented at COSA's 49th Annual Scientific Meeting, 02 November 2022 - 04 November 2022, https://onlinelibrary.wiley.com/doi/10.1111/ajco.13869